Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch. [electronic resource]
Producer: 20140808Description: 1247-52 p. digitalISSN:- 1534-6080
- Adult
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Boston
- Combined Modality Therapy
- Communicable Diseases -- etiology
- Complement System Proteins -- immunology
- Cytotoxicity, Immunologic
- Desensitization, Immunologic -- methods
- Female
- Graft Rejection -- blood
- Graft Survival -- drug effects
- HLA Antigens -- immunology
- Histocompatibility
- Humans
- Immunoglobulins, Intravenous -- therapeutic use
- Immunosuppressive Agents -- therapeutic use
- Isoantibodies -- blood
- Kaplan-Meier Estimate
- Kidney Transplantation -- adverse effects
- Living Donors
- Male
- Middle Aged
- Neoplasms -- etiology
- Plasmapheresis
- Risk Factors
- Rituximab
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.